161 related articles for article (PubMed ID: 11994390)
1. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Fujii A; Sakamoto Y; Yamauchi N; Shiota G; Terakawa N
J Clin Endocrinol Metab; 2002 May; 87(5):2376-83. PubMed ID: 11994390
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer invasion depends on cancer-derived tumor necrosis factor-alpha and stromal derived hepatocyte growth factor.
Choi DS; Kim HJ; Yoon JH; Yoo SC; Jo H; Lee SY; Min CK; Ryu HS
Int J Cancer; 2009 Jun; 124(11):2528-38. PubMed ID: 19230022
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways.
Yoshida S; Harada T; Mitsunari M; Iwabe T; Sakamoto Y; Tsukihara S; Iba Y; Horie S; Terakawa N
J Clin Endocrinol Metab; 2004 Feb; 89(2):823-32. PubMed ID: 14764801
[TBL] [Abstract][Full Text] [Related]
6. Expression and action of hepatocyte growth factor in bovine endometrial stromal and epithelial cells in vitro.
Murakami S; Miyamoto Y; Fujiwara C; Takeuchi S; Takahashi S; Okuda K
Mol Reprod Dev; 2001 Dec; 60(4):472-80. PubMed ID: 11746958
[TBL] [Abstract][Full Text] [Related]
7. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6- and tumour necrosis factor alpha-mediated expression of hepatocyte growth factor by stromal cells and its involvement in the growth of endometriosis.
Khan KN; Masuzaki H; Fujishita A; Kitajima M; Hiraki K; Sekine I; Matsuyama T; Ishimaru T
Hum Reprod; 2005 Oct; 20(10):2715-23. PubMed ID: 16006475
[TBL] [Abstract][Full Text] [Related]
9. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
[TBL] [Abstract][Full Text] [Related]
10. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.
Matsumoto K; Nakamura T
Int J Cancer; 2006 Aug; 119(3):477-83. PubMed ID: 16453287
[TBL] [Abstract][Full Text] [Related]
12. Stromal cells of endometrial carcinoma promotes proliferation of epithelial cells through the HGF/c-Met/Akt signaling pathway.
Li M; Xin X; Wu T; Hua T; Wang H; Wang H
Tumour Biol; 2015 Aug; 36(8):6239-48. PubMed ID: 25775951
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid.
Matsumoto Y; Motoki T; Kubota S; Takigawa M; Tsubouchi H; Gohda E
Biochem Biophys Res Commun; 2008 Feb; 366(1):110-6. PubMed ID: 18053801
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
[TBL] [Abstract][Full Text] [Related]
16. HGF and c-Met in pathogenesis of endometrial carcinoma.
Li M; Xin X; Wu T; Hua T; Wang H
Front Biosci (Landmark Ed); 2015 Jan; 20(4):635-43. PubMed ID: 25553470
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N; Matsumoto K; Nakamura T
Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
[TBL] [Abstract][Full Text] [Related]
18. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Arnold JT; Lessey BA; Seppälä M; Kaufman DG
Cancer Res; 2002 Jan; 62(1):79-88. PubMed ID: 11782363
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor.
Date K; Matsumoto K; Kuba K; Shimura H; Tanaka M; Nakamura T
Oncogene; 1998 Dec; 17(23):3045-54. PubMed ID: 9881707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
